ARTICLE | Clinical News
Corlux mifepristone: Phase III data
January 3, 2011 8:00 AM UTC
Corlux was well tolerated with the majority of serious adverse events determined to be unrelated to treatment. Adverse events related to treatment included symptoms of adrenal insufficiency, endometri...